News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,673 Results
Type
Article (24402)
Company Profile (147)
Press Release (433124)
Section
Business (125231)
Career Advice (492)
Deals (20630)
Drug Delivery (43)
Drug Development (79260)
Employer Resources (44)
FDA (12634)
Job Trends (9348)
News (234993)
Policy (18811)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (2)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 Biotech Bay Standard (1)
Academia (1715)
Academic (1)
Accelerated approval (3)
Adcomms (27)
Allergies (76)
Alliances (33802)
ALS (87)
Alzheimer's disease (1331)
Antibody-drug conjugate (ADC) (109)
Approvals (12633)
Artificial intelligence (222)
Autoimmune disease (14)
Automation (13)
Bankruptcy (148)
Best Places to Work (8261)
BIOSECURE Act (11)
Biosimilars (65)
Biotechnology (114)
Bladder cancer (59)
Brain cancer (24)
Breast cancer (246)
Cancer (1946)
Cardiovascular disease (150)
Career advice (427)
Career pathing (14)
CAR-T (141)
Cell therapy (378)
Cervical cancer (19)
Clinical research (65586)
Collaboration (695)
Compensation (381)
Complete response letters (22)
COVID-19 (2054)
CRISPR (33)
C-suite (185)
Cystic fibrosis (90)
Data (1926)
Decentralized trials (2)
Denatured (15)
Depression (41)
Diabetes (217)
Diagnostics (5131)
Digital health (15)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (99)
Drug pricing (25)
Drug shortages (11)
Duchenne muscular dystrophy (76)
Earnings (48699)
Editorial (17)
Employer branding (3)
Employer resources (42)
Events (73309)
Executive appointments (573)
FDA (13646)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (639)
Gene editing (91)
Generative AI (23)
Gene therapy (251)
GLP-1 (516)
Government (2297)
Grass and pollen (2)
Guidances (34)
Healthcare (13873)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (98)
Indications (26)
Infectious disease (2161)
Inflammatory bowel disease (135)
Inflation Reduction Act (2)
Influenza (42)
Intellectual property (73)
Interviews (67)
IPO (11115)
IRA (8)
Job creations (1504)
Job search strategy (387)
Kidney cancer (10)
Labor market (17)
Layoffs (281)
Leadership (5)
Legal (2328)
Liver cancer (61)
Lung cancer (289)
Lymphoma (128)
Machine learning (3)
Management (14)
Manufacturing (184)
MASH (55)
Medical device (9356)
Medtech (9356)
Mergers & acquisitions (10004)
Metabolic disorders (508)
Multiple sclerosis (65)
NASH (14)
Neurodegenerative disease (83)
Neuropsychiatric disorders (19)
Neuroscience (1790)
NextGen: Class of 2025 (3908)
Non-profit (2446)
Northern California (2226)
Now hiring (19)
Obesity (244)
Opinion (135)
Ovarian cancer (68)
Pain (74)
Pancreatic cancer (74)
Parkinson's disease (131)
Partnered (13)
Patents (155)
Patient recruitment (95)
Peanut (44)
People (37509)
Pharmaceutical (35)
Pharmacy benefit managers (1)
Phase I (21105)
Phase II (29229)
Phase III (21189)
Pipeline (965)
Podcasts (29)
Policy (29)
Postmarket research (2068)
Preclinical (7560)
Press Release (29)
Prostate cancer (88)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (326)
Real estate (2895)
Recruiting (16)
Regulatory (15831)
Reports (24)
Research institute (1840)
Resumes & cover letters (70)
Rett syndrome (3)
RNA editing (4)
RSV (24)
Schizophrenia (59)
Series A (118)
Series B (77)
Service/supplier (8)
Sickle cell disease (41)
Southern California (1933)
Special edition (12)
Spinal muscular atrophy (143)
Sponsored (16)
Startups (2391)
State (1)
Stomach cancer (12)
Supply chain (40)
The Weekly (14)
United States (18193)
Vaccines (473)
Venture capitalists (22)
Webinars (7)
Weight loss (132)
Women's health (30)
Worklife (5)
Date
Today (212)
Last 7 days (684)
Last 30 days (2520)
Last 365 days (29342)
2025 (7201)
2024 (30003)
2023 (33364)
2022 (41434)
2021 (43287)
2020 (39941)
2019 (30883)
2018 (23289)
2017 (24008)
2016 (21915)
2015 (25667)
2014 (18537)
2013 (13916)
2012 (14574)
2011 (14995)
2010 (14067)
Location
Africa (373)
Alabama (41)
Alaska (3)
Arizona (114)
Arkansas (11)
Asia (27878)
Australia (5428)
California (5032)
Canada (1502)
China (432)
Colorado (214)
Connecticut (246)
Delaware (124)
Europe (63610)
Florida (666)
Georgia (164)
Idaho (39)
Illinois (345)
India (16)
Indiana (227)
Iowa (4)
Japan (131)
Kansas (74)
Kentucky (20)
Louisiana (5)
Maine (25)
Maryland (637)
Massachusetts (3722)
Michigan (129)
Minnesota (234)
Mississippi (1)
Missouri (55)
Montana (27)
Nebraska (16)
Nevada (41)
New Hampshire (53)
New Jersey (1363)
New Mexico (23)
New York (1378)
North Carolina (789)
North Dakota (4)
Northern California (2226)
Ohio (153)
Oklahoma (14)
Oregon (29)
Pennsylvania (1064)
Puerto Rico (6)
Rhode Island (13)
South America (493)
South Carolina (15)
Southern California (1933)
Tennessee (73)
Texas (763)
Utah (132)
Virginia (107)
Washington D.C. (39)
Washington State (458)
West Virginia (1)
Wisconsin (45)
457,673 Results for "4g clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Humhealth Unveils Remote Patient Monitoring With Advanced 4G Device Configuration and 4G Watch
Humhealth, a leading provider of innovative remote care solutions, has the capability to integrate with an advanced 4G Telehealth Gateway Hub and 4G vital monitoring devices.
May 1, 2024
·
3 min read
Press Releases
Nuralogix Announces Its Next-Generation Anura® MagicMirror™: Advanced Health Monitoring Now with 4G Connectivity
March 18, 2025
·
4 min read
Press Releases
IVOS Medical Announces BOSS G4™ Video Laryngoscope Sheath Designed to Improve Intubation Safety in High-Risk Patients
January 22, 2025
·
2 min read
Deals
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2024
G1 Therapeutics, Inc. today announced the grant of inducement stock options exercisable for 4,650 shares of G1’s common stock and 2,400 restricted stock units (RSUs) to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (the “Amended and Restated 2021 Plan”).
June 5, 2024
·
2 min read
FDA Grants Clearance to Gel4Med: Breakthroughs in Wound Management with G4Derm and G4Derm Plus
Gel4Med, an innovative biomaterials company, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first biosynthetic matrix products, G4Derm and G4Derm Plus.
October 23, 2023
·
3 min read
Press Releases
MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use
January 15, 2025
·
3 min read
Biotech Beach
Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today unveiled the G4X™ Spatial Sequencer.
February 5, 2024
·
9 min read
Policy
U.S. FDA Approves MedMira’s Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
MedMira Inc. proudly announces the successful attainment of 510 clearance for the HIV-2 claim on the Reveal® G4 Rapid HIV-1/2 antibody test in the United States.
December 13, 2023
·
3 min read
Bio NC
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 01, 2023
G1 Therapeutics, Inc., a commercial-stage oncology company, announced the grant of inducement stock options exercisable for 4,700 shares of G1’s common stock and 2,300 restricted stock units to one hired employee under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.
December 1, 2023
·
2 min read
Gel4Med Receives Recognition in Podiatry Today for their G4Derm Product Line as a Top 10 Innovations in Podiatry
July 9, 2024
·
4 min read
1 of 45,768
Next
